Steven Young has extensive experience in the pharmaceutical industry, currently serving as a Sr. Alzheimer’s Therapeutic Specialist at Eisai Canada since November 2024 and as a Specialty Representative - Neurology at Lundbeck since October 2022, where responsibilities include the launch of the novel mAb agent Vyepti (Eptinezumab) for migraine prevention in British Columbia and Northern Alberta. Previous roles include Key Account Manager at Sanofi Genzyme from April 2015 to May 2023, Territory Manager at UCB Pharma from August 2010 to June 2015, and Territory Sales Manager at EMD Serono, Inc. from May 2000 to July 2010. Steven Young holds a Bachelor of Applied Science (BASc) from the University of Alberta.
This person is not in any teams
This person is not in any offices